These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15499695)

  • 21. Topiramate: new indication. Migraine prevention: best avoided.
    Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topiramate: a new antiepileptic drug.
    Privitera MD
    Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of topiramate in the treatment of focal epilepsy in children].
    Kremenchugskaia MR; Globa OV; Kuzenkova LM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):33-8. PubMed ID: 24430032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacological and clinical review on topiramate, a new antiepileptic drug.
    Perucca E
    Pharmacol Res; 1997 Apr; 35(4):241-56. PubMed ID: 9264038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trial.
    Al Ajlouni S; Shorman A; Daoud AS
    Seizure; 2005 Oct; 14(7):459-63. PubMed ID: 16087357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate monotherapy use in women with and without epilepsy: pregnancy and neonatal outcomes.
    Castilla-Puentes R; Ford L; Manera L; Kwarta RF; Ascher S; Li Q
    Epilepsy Res; 2014 May; 108(4):717-24. PubMed ID: 24598456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypohidrosis related to the administration of topiramate to children.
    Arcas J; Ferrer T; Roche MC; Martínez-Bermejo A; López-Martín V
    Epilepsia; 2001 Oct; 42(10):1363-5. PubMed ID: 11737174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
    Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
    Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects.
    Coppola G; Verrotti A; Resicato G; Ferrarelli S; Auricchio G; Operto FF; Pascotto A
    Epilepsy Behav; 2008 Feb; 12(2):253-6. PubMed ID: 17962081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
    Watemberg N; Goldberg-Stern H; Ben-Zeev B; Berger I; Straussberg R; Kivity S; Kramer U; Brand N; Lerman-Sagie T
    J Child Neurol; 2003 Apr; 18(4):258-62. PubMed ID: 12760428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience.
    Mohamed K; Appleton R; Rosenbloom L
    Seizure; 2000 Mar; 9(2):137-41. PubMed ID: 10845739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian study.
    Baker GA; Currie NG; Light MJ; Schneiderman JH;
    Seizure; 2002 Jan; 11(1):6-15. PubMed ID: 11888254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial.
    Tartara A; Sartori I; Manni R; Galimberti CA; Di Fazio M; Perucca E
    Ital J Neurol Sci; 1996 Dec; 17(6):429-32. PubMed ID: 8978450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy.
    Groselj J; Guerrini R; Van Oene J; Lahaye M; Schreiner A; Schwalen S;
    Acta Neurol Scand; 2005 Sep; 112(3):144-50. PubMed ID: 16097955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate: a review of its use in the treatment of epilepsy.
    Lyseng-Williamson KA; Yang LP
    Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.
    Langtry HD; Gillis JC; Davis R
    Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of weight loss in adults with topiramate-treated epilepsy.
    Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U
    Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.